Navigation Links
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Date:5/19/2008

ies Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated future financial results and product development. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to the uncertain, lengthy and expensive clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues; (ii) risks related to achieving positive clinical trial results; (iii) the results of the InterMune CAPACITY trials of pirfenidone may differ materially from those of the Shionogi & Co., Ltd. Phase 3 trial of pirfenidone in Japan; (iv) the designation of pirfenidone for Fast Track status by the FDA does not guarantee that the FDA will grant Priority Review of the NDA filed by InterMune in connection with the approval of pirfenidone for the treatment of IPF in the United States. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web site at http://www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Progress on Pirfenidone in IPF
2. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Announces Start of Phase 1b Trial of ITMN-191
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
7. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
10. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Broadened Diagnostic Criteria and Growing Adult ... Patent Expirations ... to 2020 - Broadened Diagnostic Criteria ...
(Date:8/28/2014)... --  RapidForce , an innovative muscle support and pain ... professional tennis player John Isner . Currently the ... competitions to help with knee support. He is wearing ... US Open Tennis Championships. Fifteen times ... a revolutionary hybrid of a brace and kinesiology tape. ...
(Date:8/28/2014)... , Aug. 28, 2014 The Leukemia ... a partnership to advance an experimental cancer vaccine ... an asymptomatic stage of myeloma. The ... through which LLS forges collaborations with biotechnology companies ... OncoPep is developing a vaccine, PVX-410, ...
Breaking Medicine Technology:ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 2America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 3America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 4The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2
... Jan. 25, 2011 Mylan Inc. (Nasdaq: MYL ... agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, ... mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, ... 10 mg/80 mg, known generically as Amlodipine Besylate/Atorvastatin Calcium Tablets. ...
... 2011 eCareSoft recently launched eCS Inpatient EHR V1.2 ... for small and medium hospitals. eCS,s uniqueness is the ... management systems into a single web-based software solution. The ... reduced costs and simplified deployment. "eCS is ...
Cached Medicine Technology:Mylan Announces Caduet® Settlement Agreement 2eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals 2
(Date:8/28/2014)... 2014 Parker Waichman LLP, a national ... fighting to ensure that the heroes of 9/11 are ... to WTC victims who developed 9/11-related cancer was reaffirmed ... Office (GAO). According to a statement issued by ... is entitled “World Trade Center Health Program: Approach Used ...
(Date:8/28/2014)... Watertown, MA (PRWEB) August 28, 2014 ... , is delighted to present its new Kids’ Share, which ... Share will encourage kids (and their parents) to get into ... their very own vegetable share. Each week the Kids’ Share ... fabulous veggies, shares will include activities for kids, recipes from ...
(Date:8/28/2014)... August 28, 2014 Clarity PSO ... been re-certified as a federal Patient Safety Organization (PSO) ... Agency for Healthcare Research and Quality (AHRQ). Clarity PSO ... expertise and services following the true intentions of the ... , ”We are proud and eager to continue our ...
(Date:8/28/2014)... 2014 (HealthDay News) -- Having greater amounts of yellow ... see distant objects in hazy conditions, a new study ... researchers simulated hazy conditions in order to test the ... pigment (also called macular pigment) in their eyes. ... which represents accumulations of the nutrients lutein and zeaxanthin, ...
(Date:8/28/2014)... August 28, 2014 GreenRushReview.com, a ... recently launched a “Video” section located at ... information on various cannabis companies in video format. ... an assortment of news clips, interviews, and other ... A portion of the videos can also be ...
Breaking Medicine News(10 mins):Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 2Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 4Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3
... perpetual inventory management system designed to meet unique ... and GAINESVILLE, Fla., Jan. 29 Omnicell, Inc. ... of system solutions to acute healthcare facilities, and ... Specialty supply chain management systems (formerly known as ...
... 29 The Shambhala Meditation Center of Los Angeles will ... master of Quigong - an ancient practice of physical fitness, ... to balance and retain youthfulness in the body. The ... & 8th at the Center for the Arts in Eagle ...
... Mettler-Toledo,International Inc. (NYSE: MTD ) today announced ... results on Thursday, February 5, 2009,at 5:00 p.m. Eastern Time. ... on the Company,s website. A replay of the webcast ... METTLER TOLEDO is a leading global supplier of precision ...
... drug-free approach to common childhood ailments, complement pediatricians.ARLINGTON, ... parents are adding pediatric chiropractic care as an ... data indicates that the percentage of chiropractic patients ... least 8.5 percent since 1991, says the American ...
... between two important protein kinase signaling pathways that are ... in the January 30th issue of the journal ... multiple types of cancer. , The protein kinase LKB1 ... pathway couples energy metabolism with cell growth, proliferation and ...
... The commonwealth,s latest statewide survey on uninsured ... health insurance coverage -- an increase from a similar ... "Overall, the study showed that increases in uninsured numbers ... certain ethnic groups and most geographic areas," Ario said. ...
Cached Medicine News:Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 2Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 3Health News:World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8 2Health News:Increasing Number of Children Receive Pediatric Chiropractic Care 2Health News:Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1 2Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 2Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 3Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: